Comparative Effectiveness of Ustekinumab Versus Vedolizumab in Treating Crohn's Disease After Failure of Anti-TNF Agents: Real-World Evidence

被引：0
|
作者：
Alamer, A. [1 ]
Al Lehaibi, L. [2 ]
Alomar, M. [2 ]
Aldhuwayan, F. [2 ]
Alshouish, S. [2 ]
Al-Ali, A. [3 ]
Almudhry, Z. [4 ]
Almulhim, A. [5 ]
Althagafi, A. [6 ]
Aldosari, S. [7 ]
Alameel, T. [8 ]
机构：
[1] Prince Sattam Bin Abdulaziz Univ, Dept Clin Pharm, Alkharj, Saudi Arabia
[2] Eastern Hlth Cluster Dammam Med Complex, Dept Clin Pharm, Dammam, Saudi Arabia
[3] Eastern Hlth Cluster Dhahran Eye Specialist Hosp, Dept Clin Pharm, Dhahran, Saudi Arabia
[4] Eastern Hlth Cluster Dammam Med Complex, Dept Med, Dammam, Saudi Arabia
[5] King Faisal Univ, Dept Pharm Practice, Coll Clin Pharm, Alhofuf, Saudi Arabia
[6] King Abdulaziz Univ, Dept Pharm Practice, Fac Pharm, Jeddah, Saudi Arabia
[7] Prince Sattam Bin Abdulaziz Univ, Dept Clin Pharm, Coll Pharm, Alkharj, Saudi Arabia
[8] King Fahad Specialist Hosp Dammam, Dept Med, Dammam, Saudi Arabia
来源：
JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P688
引用
收藏
页码：I1297 / I1297
页数：1
相关论文
共 50 条
  • [21] Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
    Cassandra Rayer
    Maria Nachury
    Arnaud Bourreille
    Xavier Roblin
    Laurent Peyrin-Biroulet
    Stephanie Viennot
    Mathurin Flamant
    David Laharie
    Bénédicte Caron
    Marie Dewitte
    Laurent Siproudhis
    Mathurin Fumery
    Guillaume Bouguen
    BMC Gastroenterology, 22
  • [22] Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study
    Cassandra, Rayer
    Nachury, Maria
    Arnaud, Bourreille
    Xavier, Roblin
    Laurent, Peyrin-Biroulet
    Stephanie, Viennot
    Mathurin, Flamant
    David, Laharie
    Benedicte, Caron
    Marie, Dewitte
    Laurent, Siproudhis
    Mathurin, Fumery
    Guillaume, Bouguen
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [23] The outcome of Crohn's disease patients refractory to anti-TNF and either vedolizumab or ustekinumab
    Kassouri, Liza
    Amiot, Aurelien
    Kirchgesner, Julien
    Treton, Xavier
    Allez, Mathieu
    Bouhnik, Yoram
    Beaugerie, Laurent
    Carbonnel, Franck
    Meyer, Antoine
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (10) : 1148 - 1155
  • [24] Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF,Vedolizumab or Ustekinumab: A Real-World Multicentre European Study
    Yanai, Henit
    Kagramanova, Anna
    Knyazev, Oleg
    Sabino, Joao
    Haenen, Shana
    Mantzaris, Gerassimos J.
    Mountaki, Katerina
    Armuzzi, Alessandro
    Pugliese, Daniela
    Furfaro, Federica
    Fiorino, Gionata
    Drobne, David
    Kurent, Tina
    Yassin, Sharif
    Maharshak, Nitsan
    Castiglione, Fabiana
    de Sire, Roberto
    Nardone, Olga Maria
    Farkas, Klaudia
    Molnar, Tamas
    Krznaric, Zeljko
    Brinar, Marko
    Chashkova, Elena
    Margolin, Moran Livne
    Kopylov, Uri
    Bezzio, Cristina
    Shitrit, Ariella Bar-Gil
    Lukas, Milan
    Chaparro, Maria
    Truyens, Marie
    Nancey, Stephane
    Lobaton, Triana
    Gisbert, Javier P.
    Saibeni, Simone
    Bacsur, Peter
    Bossuyt, Peter
    Schulberg, Julien
    Hoentjen, Frank
    Vigano, Chiara
    Palermo, Andrea
    Torres, Joana
    Reves, Joana
    Karmiris, Konstantinos
    Velegraki, Magdalini
    Savarino, Edoardo
    Markopoulos, Panagiotis
    Tsironi, Eftychia
    Ellul, Pierre
    Suarez, Cristina Calvino
    Weisshof, Roni
    JOURNAL OF CROHNS & COLITIS, 2022, 16 (12): : 1882 - 1892
  • [25] Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
    Cassandra Rayer
    Maria Nachury
    Arnaud Bourreille
    Xavier Roblin
    Laurent Peyrin-Biroulet
    Stephanie Viennot
    Mathurin Flamant
    David Laharie
    Bénédicte Caron
    Marie Dewitte
    Laurent Siproudhis
    Mathurin Fumery
    Guillaume Bouguen
    BMC Gastroenterology, 23
  • [26] Early real-world effectiveness of ustekinumab for Crohn's disease
    Harris, Richard James
    McDonnell, Martin
    Young, David
    Bettey, Marion
    Downey, Louise
    Pigott, Lucinda
    Felwick, Richard
    Gwiggner, Markus
    Cummings, J. R. Fraser
    FRONTLINE GASTROENTEROLOGY, 2020, 11 (02) : 111 - 116
  • [27] THE REAL-WORLD EFFECTIVENESS OF USTEKINUMAB IN THE TREATMENT OF CROHN'S DISEASE
    Johnson, Amanda M.
    Barsky, Maria
    Ahmed, Waseem
    Zullow, Samantha
    Galati, Jonathan S.
    Jairath, Vipul
    Narula, Neeraj
    Peerani, Farhad
    Click, Benjamin H.
    Coburn, Elliot
    Dang, Thucnhi T.
    Gold, Stephanie
    Agrawal, Manasi
    Garg, Rajat
    Aggarwal, Manik
    Mohammad, Danah
    Halloran, Brendan P.
    Kochhar, Gursimran
    Todorowski, Hannah
    Mohy-Ud-Din, Nabeeha
    Izanec, James L.
    Teeple, Amanda M.
    Gasink, Christopher
    Muser, Erik
    Ding, Zhijie
    Swaminath, Arun
    Lakhani, Komal
    Hogan, Daniel
    Datta, Samit
    Ungaro, Ryan C.
    Singh, Siddharth
    Boland, Brigid
    Bohm, Matthew
    Fischer, Monika
    Sashi, Sagi
    Afzali, Anita
    Ullman, Thomas
    Lawlor, Garrett
    Baumgart, Daniel C.
    Chang, Shannon
    Hudesman, David
    Lukin, Dana J.
    Scherl, Ellen J.
    Colombel, Jean Frederic
    Sands, Bruce E.
    Siegel, Corey A.
    Regueiro, Miguel D.
    Sandborn, William J.
    Bruining, David H.
    Kane, Sunanda V.
    GASTROENTEROLOGY, 2021, 160 (06) : S121 - S121
  • [28] Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive Crohn's disease patients: results from the EVOLVE study
    Bressler, B.
    Mantzaris, G.
    Silverberg, M.
    Zezos, P.
    Stein, D.
    Colby, C.
    Lissoos, T.
    Lopez, C.
    Natsios, A.
    Radulescu, G.
    Patel, H.
    Demuth, D.
    Yarur, A.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S427 - S428
  • [29] Real-World Anti-TNF Dose Escalation in Patients With Crohn's Disease
    Rubin, David T.
    Kane, Sunanda
    Jaganathan, Srihari
    Palmer, Liisa
    Cyhaniuk, Anissa
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2015, 7 (05) : E135 - E140
  • [30] REAL-WORLD EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND ANTI-TNF IN BIOLOGIC-NAIVE CROHN'S DISEASE PATIENTS: RESULTS FROM THE EVOLVE STUDY
    Mantzaris, Gerassimos J.
    Yarur, Andres J.
    Silverberg, Mark S.
    Zezos, Petros
    Stein, Dara
    Kim, Hankyul
    Lissoos, Trevor
    Lopez, Claudia
    Natsios, Athanasios
    Radulescu, Gabriela
    Patel, Haridarshan
    Demuth, Dirk
    Bressler, Brian
    GASTROENTEROLOGY, 2019, 156 (06) : S638 - S638
12345